Development of a new generation of biostable nucleic acid antibodies (aptamers), catalysts and nanostructures for precision biomedicine using synthetic genetic systems

Project: Research

Project Details

StatusActive
Effective start/end date2/02/202428/02/2026

Collaborative partners

Funding

  • Wellcome Trust: £454,362.51